Clinical Trials
Overcoming Regulatory Barriers
To Fast-Track Clinical Trials
The last decade has seen a significant increase in the number of global clinical trials being conducted in Asia In China and India the number of new global studies approved rose from less than in each country in to more than in India and to more than in China in This growth is due to a number of factors which have aligned to make Asia an attr...
Getting the Most from your Outsourcing Partner
Executing more cost effective and successful clinical trials
Multinational biopharmaceutical companies abandoned the practice of performing all of their Research Development RD functions in house years ago but the drivers behind the decision to outsource are changing While the need to reduce fixed costs remains a primary reason for big pharmas dependence on outsourcing partners a recent study found that imp...
Outsourcing CRO Services to China
The staffing challenge
The business benefits of outsourcing Contract Research Organisation CRO services to China are compelling in todays pharmaceutical marketplace and global economy Labour rates in China are much lower than in the West and additionally China offers a large pool of highly educated research talent that can be readily tapped to staff projects carried ou...
Human Antibody Discovery
VelocImmune - A novel platform
Antibody therapeutics are one of the fastestgrowing drug classes and take advantage of the endogenous immune system for the creation of novel therapeutics Antibodies are superior drug candidates because they are a natural constituent of the human immune response and possess many important favourable pharmacologic qualities such as halflife tolerabi...
Proteomic Biomarkers
Transforming drug development
The success of many investigational drugs is dependent on matching treatments with the appropriate target populations Variability in response to therapy both with regards to efficacy and to adverse events is leading the pharmaceutical industry down the path of personalised medicine Further pushing the process along are government and private insura...
Personalised Healthcare
Hitting the mark
Personalised Healthcare is not a novel concept but has undergone a continual evolution More than years ago diagnosis and treatments were based on what could be seen smelt tasted palpated or intuited About years ago diagnosis and treatment started to be based on a greater understanding of surgery biochemistry and cellular processes Today the focus...
Advertorial
Added-Value Clinical Trials
As part of a World Trade Organization agreement signed in India has committed itself to honouring product patents from This change in intellectual property law is expected to boost growth in the clinical trials market Previously Indias patent laws only recognised processes with no specific requirement for clinical trials As a result most of the...
Clinical Supplies
Adapting to trial demand
Whether it is adding new sites in an existing study or adding new doses clinical customers look to the supply chain to be agile with supplies and respond in turn with flexibility while maintaining timely delivery There are many challenges facing clinical supplies and how the supply chain can be prepared to meet the demand changes Challenges faci...
New Demand, New Horizons
Both the quantity and the quality of multinational multicentre trials conducted in the Asia Pacific region are on the increase as more and more trials are shifted from developed Western nations to developing countries in Asia Latin America and Eastern and Central Europe So why is Asia Pacific in particular such a popular option There is a projec...
Unleashing the Industry’s True Potential
Closed loop clinical trial supply chain
The lead time for conducting clinical trials is one of the critical paths in the launch of a new product for life sciences companies while providing clinical supplies at the right time at the right site is the most daunting challenge faced by the clinical operations team Changes in the trial design and uncertainty in the demand of clinical supplies...
